| Primary |
| Drug Use For Unknown Indication |
100.0% |
|
| Product Quality Issue |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
39.3% |
| Prophylaxis |
19.6% |
| Colorectal Cancer |
10.7% |
| Bone Marrow Conditioning Regimen |
3.6% |
| Non-hodgkin's Lymphoma |
3.6% |
| Nutritional Supplementation |
3.6% |
| Precursor T-lymphoblastic Lymphoma/leukaemia Recurrent |
3.6% |
| Child Maltreatment Syndrome |
1.8% |
| Convulsion Prophylaxis |
1.8% |
| Drug Toxicity |
1.8% |
| Hiv Infection |
1.8% |
| Mucosal Inflammation |
1.8% |
| Oropharyngeal Candidiasis |
1.8% |
| Ph Urine Abnormal |
1.8% |
| Renal Failure Acute |
1.8% |
| Supportive Care |
1.8% |
|
| Bone Marrow Failure |
8.3% |
| Candidiasis |
8.3% |
| Cerebral Ischaemia |
8.3% |
| Grand Mal Convulsion |
8.3% |
| Nephropathy Toxic |
8.3% |
| Peripheral Vascular Disorder |
8.3% |
| Renal Failure Acute |
8.3% |
| Tinnitus |
8.3% |
| Transient Ischaemic Attack |
8.3% |
| Tremor |
8.3% |
| Venoocclusive Liver Disease |
8.3% |
| Weight Decreased |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Drug Use For Unknown Indication |
14.9% |
| Metastases To Bone |
8.3% |
| Breast Cancer |
7.6% |
| Colorectal Cancer Metastatic |
4.6% |
| Headache |
4.6% |
| Breast Cancer Metastatic |
3.0% |
| Pain |
3.0% |
| Metastatic Renal Cell Carcinoma |
2.9% |
| Ear Pain |
2.7% |
| Multiple Myeloma |
2.7% |
| Oesophageal Carcinoma |
2.7% |
| Diarrhoea |
2.4% |
| Nausea |
2.2% |
| Anxiety |
1.9% |
| Colony Stimulating Factor Prophylaxis |
1.9% |
| Crohn's Disease |
1.7% |
| Reflux Gastritis |
1.7% |
| Supplementation Therapy |
1.7% |
| Immunosuppression |
1.5% |
|
| Vision Blurred |
20.7% |
| Viral Pharyngitis |
8.7% |
| Wound Dehiscence |
8.7% |
| Renal Failure Acute |
6.5% |
| Vomiting |
5.4% |
| Disease Progression |
4.3% |
| Temperature Intolerance |
4.3% |
| Throat Irritation |
4.3% |
| Wound Infection |
4.3% |
| Faecalith |
3.3% |
| Pneumonia Aspiration |
3.3% |
| Respiratory Depression |
3.3% |
| Rhabdomyolysis |
3.3% |
| Somnolence |
3.3% |
| Tumour Necrosis |
3.3% |
| Wheelchair User |
3.3% |
| Xerosis |
3.3% |
| Death |
2.2% |
| Depression |
2.2% |
| Dyspnoea |
2.2% |
|
